Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 13 11 2018
accepted: 17 01 2019
entrez: 22 2 2019
pubmed: 23 2 2019
medline: 7 1 2020
Statut: epublish

Résumé

Tolerogenic dendritic cells and T-regulatory cells are two immune cell populations with the potential to prevent the onset of clinical stage type 1 diabetes, and manage the beginning of underlying autoimmunity, at the time-at-onset and onwards. Initial phase I trials demonstrated that the administration of a number of these cell populations, generated

Identifiants

pubmed: 30787930
doi: 10.3389/fimmu.2019.00148
pmc: PMC6372505
doi:

Substances chimiques

Autoantigens 0

Banques de données

ClinicalTrials.gov
['NCT00445913', 'NCT02354911']

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

148

Références

J Immunol. 1997 Jun 15;158(12):5676-84
pubmed: 9190916
Nutrients. 2015 Sep 21;7(9):8127-51
pubmed: 26402698
Front Immunol. 2018 Apr 06;9:682
pubmed: 29686676
Diabetes. 2005 Dec;54 Suppl 2:S52-61
pubmed: 16306341
J Immunol Res. 2018 Feb 14;2018:5463879
pubmed: 29651443
Ther Deliv. 2015;6(8):973-87
pubmed: 26272222
PeerJ. 2016 Aug 30;4:e2300
pubmed: 27635311
J Autoimmun. 2018 Jun;90:39-48
pubmed: 29439835
Biol Blood Marrow Transplant. 2007 Jan;13(1 Suppl 1):23-32
pubmed: 17222766
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922
J Transl Med. 2016 Dec 1;14(1):332
pubmed: 27903296
Eur J Immunol. 2001 Sep;31(9):2547-57
pubmed: 11536152
Am J Med. 2018 Jul;131(7):752-754
pubmed: 29496503
Immunol Res. 2011 Aug;50(2-3):130-52
pubmed: 21476100
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319
Int J Hematol. 2005 Apr;81(3):197-203
pubmed: 15814330
Front Immunol. 2018 Feb 16;9:290
pubmed: 29503651
Pediatr Endocrinol Rev. 2008 Jun;5(4):873-9
pubmed: 18552749
Autoimmun Rev. 2006 Jul;5(6):419-23
pubmed: 16890897
Ann N Y Acad Sci. 2003 Nov;1005:222-5
pubmed: 14679064
J Immunol. 2001 Apr 1;166(7):4312-8
pubmed: 11254683
J Exp Med. 2006 Jul 10;203(7):1693-700
pubmed: 16818676
Diabetes Care. 2012 Sep;35(9):1817-20
pubmed: 22723342
Crit Rev Clin Lab Sci. 2007;44(4):339-63
pubmed: 17558653
Clin Immunol. 2013 Aug;148(2):237-45
pubmed: 23773922
Transplant Proc. 1997 Feb-Mar;29(1-2):1094-5
pubmed: 9123216
Cold Spring Harb Perspect Med. 2012 Apr;2(4):a007781
pubmed: 22474615
Sci Transl Med. 2015 Nov 25;7(315):315ra189
pubmed: 26606968
Int J Pharm. 2018 Feb 15;537(1-2):223-244
pubmed: 29288095
J Exp Med. 1998 Dec 7;188(11):2175-80
pubmed: 9841930
Blood. 2000 May 15;95(10):3162-7
pubmed: 10807783
J Immunol. 1999 Jun 1;162(11):6473-81
pubmed: 10352262
Clin Immunol. 2014 Jul;153(1):23-30
pubmed: 24704576
PLoS One. 2012;7(12):e52456
pubmed: 23300676
Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii90-6
pubmed: 19022823
Immunol Res. 2011 Aug;50(2-3):124-9
pubmed: 21717078
J Immunol Res. 2015;2015:856707
pubmed: 26543876
PLoS Med. 2016 Oct 11;13(10):e1002139
pubmed: 27727279
Lancet. 2016 Oct 22;388(10055):2023-2038
pubmed: 27156434
EMBO J. 2014 May 16;33(10):1104-16
pubmed: 24737868
Nat Immunol. 2001 Jul;2(7):585-9
pubmed: 11429541
Eur J Immunol. 2009 May;39(5):1334-43
pubmed: 19350558
J Immunol. 2006 Apr 15;176(8):4590-9
pubmed: 16585549
J Exp Med. 2005 Jul 18;202(2):203-7
pubmed: 16027234
PLoS One. 2014 Jan 17;9(1):e83575
pubmed: 24465383
Diabetes Care. 2011 Sep;34(9):2026-32
pubmed: 21680720
Cell Mol Immunol. 2015 Sep;12(5):566-71
pubmed: 26051475
Blood. 2004 Jul 1;104(1):26-33
pubmed: 15026316
Nature. 1997 Oct 16;389(6652):737-42
pubmed: 9338786
Ann Rheum Dis. 2017 Jan;76(1):227-234
pubmed: 27117700
Ann Rheum Dis. 2010 Nov;69(11):2042-50
pubmed: 20551157
Semin Immunol. 2006 Apr;18(2):120-7
pubmed: 16464609
Diabet Med. 2019 Mar;36(3):297-307
pubmed: 30362170
Cell. 2001 Aug 10;106(3):259-62
pubmed: 11509173
Immunity. 2003 Jan;18(1):155-67
pubmed: 12530984
Nat Rev Endocrinol. 2017 May;13(5):268-277
pubmed: 27834384
Nat Med. 2013 Jun;19(6):739-46
pubmed: 23624599
Novartis Found Symp. 2003;252:226-35; discussion 235-8, 257-67
pubmed: 14609222
Front Immunol. 2012 Aug 09;3:218
pubmed: 22908013
Front Immunol. 2014 Jan 31;5:7
pubmed: 24550907
J Immunol. 2009 Feb 15;182(4):2074-83
pubmed: 19201860
Immunity. 2003 May;18(5):605-17
pubmed: 12753738
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4345-54
pubmed: 17671115
Adv Exp Med Biol. 1997;417:275-82
pubmed: 9286373
Nat Rev Immunol. 2006 Jun;6(6):476-83
pubmed: 16691244
Hum Immunol. 2002 Dec;63(12):1156-63
pubmed: 12480259
J Leukoc Biol. 2009 Feb;85(2):243-50
pubmed: 18971286
Immunology. 2007 Feb;120(2):251-60
pubmed: 17233742
Oncotarget. 2015 Jun 10;6(16):14123-38
pubmed: 26053099
Diabetes Metab J. 2011 Jun;35(3):199-206
pubmed: 21785738
J Immunol. 2001 Apr 15;166(8):5265-70
pubmed: 11290812
J Exp Med. 2006 Apr 17;203(4):1045-54
pubmed: 16567390
Int J Surg. 2015 Nov;23(Pt B):261-266
pubmed: 26253846
Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651
pubmed: 20457564
Diabetes Res Clin Pract. 2017 Nov;133:178-192
pubmed: 28965029
J Diabetes. 2019 Apr;11(4):292-300
pubmed: 30264527
Front Immunol. 2017 Oct 12;8:1279
pubmed: 29075262
Clin Exp Immunol. 2013 Nov;174(2):302-17
pubmed: 23865694
J Exp Med. 2006 Jul 10;203(7):1701-11
pubmed: 16818678
J Investig Med. 2011 Aug;59(6):881-6
pubmed: 21527855
J Crohns Colitis. 2015 Dec;9(12):1071-8
pubmed: 26303633
Sci Transl Med. 2015 Jun 3;7(290):290ra87
pubmed: 26041704
Nat Rev Immunol. 2007 Aug;7(8):610-21
pubmed: 17627284
Semin Immunol. 2011 Aug;23(4):252-63
pubmed: 21741270
Nat Immunol. 2003 Dec;4(12):1206-12
pubmed: 14578884
Blood. 2010 Aug 12;116(6):935-44
pubmed: 20448110
J Immunol. 2006 May 15;176(10):6202-10
pubmed: 16670330
Cytokine Growth Factor Rev. 2008 Feb;19(1):41-52
pubmed: 18258476
J Immunother. 2006 Jul-Aug;29(4):407-15
pubmed: 16799336
Nat Rev Immunol. 2010 Sep;10(9):664-74
pubmed: 20706277

Auteurs

Brett Eugene Phillips (BE)

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.

Yesica Garciafigueroa (Y)

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.

Carl Engman (C)

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.

Massimo Trucco (M)

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, United States.

Nick Giannoukakis (N)

Allegheny Health Network Institute of Cellular Therapeutics, Allegheny General Hospital, Pittsburgh, PA, United States.
Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH